Get information about ovarian cancer clinical trials – what they are, how they work and how you can find out more. We answer your questions about participating in a clinical trial for ovarian cancer below.
Clinical trials are research studies that test new medical treatments and procedures. Drugs and treatments are usually assessed in three phases before they can be considered as a ‘standard’ treatment option.
Builds on the findings from Phase I, improving knowledge of potential side effects and on the best dose to give.
It usually involves up to 100 people and looks at which type of cancer the treatment might work best for. If the tumours respond to treatment (either by slowing down growth or reducing the tumours), it moves to Phase III.
Many women view taking part in a clinical trial as a very positive experience. Some of the benefits include:
getting a new treatment before it is widely available
being one of the first to benefit if the drug or treatment works
receiving additional monitoring and care – you will need to attend regular tests and check-ups
helping advance medical knowledge for the benefit of women now and in the future
Studies show that people benefit from taking part, whether or not they actually receive the trial drug. This could be because trials involve additional care and monitoring at the hospital.
However, you also need to consider that new treatments are not always better than standard treatments; the new drug or treatment might not work for you; and sometimes there are unexpected side effects.
As trials compare new treatments with standard treatments, you may be selected to receive either the new treatment or the standard treatment. So by agreeing to be in a trial, it does not necessarily mean you will receive the new drug being tested.
Speak to your oncologist, who will be able to tell you about the trials in your local hospital suitable for you. If there isn’t a trial, they may be able to give you information about trials in other hospitals.
You can also find out about trials across the UK by visiting our Clinical Trials Information Centre.
As well as a helpful search tool, you’ll find information on:
- how trials are designed
- useful questions to ask your oncologist
You may need to consider travelling to another hospital for treatment.
Having discussed the possibilities for treatment with your oncologist, you may want to seek a second opinion, either at your current hospital, or one which is more involved in research and trials. Your CNS should be able to advise you on how to get a second opinion.
A drug is given a license by the European Medicines Agency (EMA) or the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK once it is deemed safe to use in a certain group of patients, and has shown to be of some benefit.
Drug manufacturers generally submit applications for licenses once the results of clinical trials are published. This process can take up to a year.
Once a drug is licensed, the National Institute of Health and Care Excellence (NICE) and the Scottish Medicines Consortium will, if asked, assess whether the drug should be used by the NHS.
They look at the clinical and cost effectiveness of the drug. In other words, does the drug in question work better than standard treatments offered (either for all patients, or for a particular group of patients)? Is the price to the NHS acceptable for the amount of benefit seen?
This process can take some considerable time, and countries within the UK may reach different conclusions.
This means it can take up to two years, or more, from results of trials being announced to the drugs being approved for use on the NHS.